Showing results (41-50 of 59) with videos related to
Sort By:
Pageof 6
Gut|February 24, 2022
Inflamed and non-inflamed classes of HCC: a revised immunogenomic classificationCarla Montironi, Florian Castet, Philipp K Haber, et al.Scientific Reports|July 30, 2024
The immunomodulatory role of paracrine signalling factor VSIG4 in peritoneal metastasesYik Yan Chong, Sasinthiran Thiagarajan, Qiu Xuan Tan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2022
Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental AgentsLaura Torrens, Marc Puigvehí, Miguel Torres-Martín, et al.Cancer Letters|October 24, 2022
IFNγ-IL-17+ CD8 T cells contribute to immunosuppression and tumor progression in human hepatocellular carcinomaYun Hua Lee, Samuel Chuah, Phuong H D Nguyen, et al.Journal for Immunotherapy of Cancer|August 28, 2020
Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinomaHarry Ho Man Ng, Ren Yuan Lee, Siting Goh, et al.Gut|July 22, 2025
Targeting Treg-fibroblast interaction to enhance immunotherapy in steatotic liver disease-related hepatocellular carcinomaAldo Prawira, Hang Xu, Yu Mei, et al.Frontiers in Immunology|September 29, 2022
Case report: Understanding the impact of persistent tissue-localization of SARS-CoV-2 on immune response activity via spatial transcriptomic analysis of two cancer patients with COVID-19 co-morbidityMai Chan Lau, Yang Yi, Denise Goh, et al.Nature Communications|January 12, 2021
Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinomaPhuong H D Nguyen, Siming Ma, Cheryl Z J Phua, et al.Hepatology Communications|August 21, 2024
GATA4 downregulation enhances CCL20-mediated immunosuppression in hepatocellular carcinomaN Jannah M Nasir, Samuel Chuah, Timothy Shuen, et al.Hepatology (Baltimore, Md.)|February 20, 2022
Hypoxia-driven immunosuppression by Treg and type-2 conventional dendritic cells in HCCSheena Suthen, Chun Jye Lim, Phuong H D Nguyen, et al.Pageof 6